APVO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
APVO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Aptevo Therapeutics's Book Value per Share for the quarter that ended in Mar. 2024 was $9.06.
During the past 12 months, Aptevo Therapeutics's average Book Value per Share Growth Rate was -93.60% per year. During the past 3 years, the average Book Value per Share Growth Rate was -44.90% per year. During the past 5 years, the average Book Value per Share Growth Rate was -44.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 11 years, the highest 3-Year average Book Value per Share Growth Rate of Aptevo Therapeutics was 472.20% per year. The lowest was -76.30% per year. And the median was -44.90% per year.
For the Biotechnology subindustry, Aptevo Therapeutics's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Aptevo Therapeutics's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Aptevo Therapeutics's 3-Year Book Growth Rate falls into.
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
Aptevo Therapeutics (NAS:APVO) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Thank you for viewing the detailed overview of Aptevo Therapeutics's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Daphne Taylor | officer: SVP, CFO | 3303 MONTE VILLA PARKWAY, BOTHELL WA 98021 |
Kevin C Tang | 10 percent owner | 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121 |
Soyoung Kwon | officer: See Remarks | APTEVO THERAPEUTICS INC., 2401 4TH AVENUE, SUITE 1050, SEATTLE WA 98121 |
Tang Capital Management Llc | 10 percent owner | 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121 |
Tang Capital Partners Lp | 10 percent owner | 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121 |
Randy Joe Maddux | officer: Senior VP, Operations | 2401 4TH AVENUE, SUITE #1050, SEATTLE WA 98121 |
Fuad El-hibri | director | 2273 RESEARCH BLVD, SUITE 400, ROCKVILLE MD 20850 |
Daniel Abdun-nabi | director | 400 PROFESSIONAL DRIVE, SUITE 400, GAITHERSBURG MD 20879 |
Marvin L White | director, officer: President and CEO | 2273 RESEARCH BLVD, SUITE 400, ROCKVILLE MD 20850 |
Barbara Lopez Kunz | director | 2401 4TH AVENUE, SUITE 1050, SEATTLE WA 98121 |
Zsolt Harsanyi | director | 2273 RESEARCH BLVD., SUITE 400, ROCKVILLE MD 20850 |
Grady Iii Grant | director | 2401 4TH AVENUE, SUITE 1050, SEATTLE WA 98121 |
Shawnte Mitchell | officer: SVP, GC and Corporate Affairs | 5959 HORTON STREET, SUITE 500, EMERYVILLE CA 94608 |
Michael Adelman | officer: SVP, Commercial Operations | 2401 4TH AVENUE, SUITE 1050, SEATTLE WA 98121 |
Jane A Gross | officer: See Remarks | 2401 4TH AVENUE, SUITE 1050, SEATTLE WA 98121 |
From GuruFocus
By ACCESSWIRE ACCESSWIRE • 03-24-2022
By ACCESSWIRE ACCESSWIRE • 01-09-2023
By ACCESSWIRE • 08-10-2023
By ACCESSWIRE • 08-02-2023
By ACCESSWIRE ACCESSWIRE • 12-12-2022
By ACCESSWIRE ACCESSWIRE • 02-13-2023
By ACCESSWIRE ACCESSWIRE • 05-11-2023
By PRNewswire • 08-10-2023
By ACCESSWIRE ACCESSWIRE • 11-15-2021
By PRNewswire PRNewswire • 03-29-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.